New polymer coating for improved cancer targeting of nanomedicine
20 May 2022
A new study published in the Journal of Controlled Release reports some intriguing developments in the tumour-targeting delivery of nanomedicines.
Preparation is key: the role of scientific due diligence in successful partnerships
20 May 2022
Small biopharma companies often need to partner with larger firms to achieve their goals, but such agreements can fail if preparations are poor. Here, Diane Seimetz and Jörg Schneider at Biopharma Excellence discuss how due diligence smooths the path to collaboration.
mRNA Unlocked: How Technology Convergence Is Driving the Next Wave
19 May 2022
The incredible success of the two mRNA vaccines against COVID-19 sparked a surge of interest and investment in this new therapeutic modality. And because mRNA is infinitely programmable, scientists are now working on deploying it towards fighting many other diseases. Our customers have already embarked on this second wave, developing mRNA drugs to treat bacterial infections, rare genetic diseases, cancer and more.
Researchers develop battery-free, smart contact lens that delivers glaucoma drugs on demand
18 May 2022
Researchers in China have put forward early studies of a smart contact lens for treating glaucoma. It aims to sense rising fluid pressures within the eye and automatically deliver medication as needed.
Russia has eliminated the shortage of therapies for epilepsy and thyroid diseases
18 May 2022
Russia’s problem with the shortage of medicines for epilepsy and thyroid diseases has been solved. This was reported in the press service of the Ministry of Health of the Russian Federation.
New antiviral class offers hope of halting rampage of treatment-resistant viruses and beyond
18 May 2022
A totally new approach to antivirals may finally provide a solution to combating viruses that have evaded traditional therapy.
Driving Commercial Success in New Era of Biopharmaceutical Innovation
17 May 2022
This new era in the biopharmaceutical industry promises to introduce a wave of innovative products, including therapies for conditions with high unmet medical needs. Driven by significant investments in research and development, there are more than 7,800 products in clinical development spanning a wide range of therapeutic areas—from cancer to cardiovascular medicine and diabetes to neurology.
17 May 2022
Russian Health Minister Mikhail Murashko proposed to consider the possibility of creating a medical association of BRICS countries during the 12th Meeting of BRICS Ministers of Health.
A pilot project of neonatal SMA screening has been launched in the Krasnodar Krai
16 May 2022
All newborns of the Krasnodar Krai will be tested for spinal muscular atrophy (SMA) and primary immunodeficiency disorders (PIDs). At the moment, in most regions of Russia, large-scale newborn screening includes only five hereditary diseases: phenylketonuria, adrenogenital syndrome (adrenal cortex dysfunction), congenital hypothyroidism, galactosemia and cystic fibrosis. Neonatal heel prick is performed on all 3 to 7-day-old newborns to identify these severe diseases at the pre-symptomatic stage.
The Cabinet of Ministers lifted the ban on the export of some medical products from the country
16 May 2022
The government has amended the lists of medical devices and consumables for pharmaceutical production, for which a temporary ban and an authorization-based procedure for export outside Russia was introduced in early March.
New polymer coating for improved cancer targeting of nanomedicine
20 May 2022
Preparation is key: the role of scientific due diligence in successful partnerships
20 May 2022
mRNA Unlocked: How Technology Convergence Is Driving the Next Wave
19 May 2022
Researchers develop battery-free, smart contact lens that delivers glaucoma drugs on demand
18 May 2022